GlaxoSmithKline Announces Major UK Manufacturing Investment

By Steve Wynne-Jones
Share this article
GlaxoSmithKline Announces Major UK Manufacturing Investment

GlaxoSmithKline (GSK) has announced it is to invest £275 million in three of its manufacturing sites in the UK.

The investment, which comes despite the recent Brexit vote, will help boost the production of the group’s medical facilities at Barnard Castle, Co. Durham; Montrose, Scotland; and Ware, Hertfordshire.

In a statement, GSK said that it views the UK as an attractive location for ‘investment in advanced manufacturing due to a number of factors including the skilled workforce, technological and scientific capabilities and infrastructure and a competitive corporate tax system’.

‘Today’s announcement reflects further investment to support our pharmaceutical pipeline and meet growing demand for our innovative portfolio of newly launched products,” said GSK chief executive Andrew Witty. “It is testament to our skilled UK workforce and the country’s leading position in life sciences that we are making these investments in advanced manufacturing here.”

© 2016 European Supermarket Magazine – your source for the latest retail news. Article by Stephen Wynne-Jones. To subscribe to ESM: The European Supermarket Magazine, click here.

Get the week's top grocery retail news

The most important stories from European grocery retail direct to your inbox every Thursday

Processing your request...

Thanks! please check your email to confirm your subscription.

By signing up you are agreeing to our terms & conditions and privacy policy. You can unsubscribe at any time.